Brief: Onxeo Provides Update on Litigation with SpeBio/SpePharm
Jan 23 (Reuters) - Onxeo SA C4X.PA :
* ONXEO SA - SUBMITTED CONCLUSIONS TO PARIS COURT OF APPEAL
CONCERNING MERITS OF LITIGATION AGAINST SPEPHARM/SPEBIO B.V
COMPANIES
* ONXEO SA - COURT'S DECISION IS EXPECTED AS EARLY AS END OF
Q4
2018
Source text for Eikon: urn:newsml:reuters.com:*:nBw3kWc9ja
Further company coverage: C4X.PA
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln